DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» PPM1D
PPM1D
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: the Silent Way of Cancer Progression
Characterization of BRCA1-Deficient Premalignant Tissues and Cancers Identifies Plekha5 As a Tumor Metastasis Suppressor
The RNA Splicing Response to DNA Damage
Phosphatases Reverse P53-Mediated Cell Cycle Checkpoints
Autocrine IFN Signaling Inducing Profibrotic Fibroblast Responses By
Supplementary Data
Identifying DNA Methylation Variation Patterns to Obtain Potential Breast
2020-02-20 Supplemental Figures. Milosevic Et Al Copy
PPM1D Is a Potential Target for 17Q Gain in Neuroblastoma1
Truncating Mutations of PPM1D Are Found in Blood DNA Samples of Lung Cancer Patients
A Comprehensive Evaluation of Pathogenic Mutations in Primary
PPM1D Is a Neuroblastoma Oncogene and Therapeutic Target in Childhood Neural
Clinical Implications of Sub-Grouping HER2 Positive Tumors by Amplicon
Usbiological Datasheet
PPM1D Is a Potential Therapeutictarget in Ovarian Clear Cell Carcinomas David S.P
Inherited Causes of Clonal Haematopoiesis in 97,691 Whole Genomes
Disease Spectrum of Breast Cancer Susceptibility Genes
The Autism-Associated Chromatin Modifier CHD8 Regulates Other
Top View
Supplementary File 1
Atlas Journal
Neurodevelopmental Disease Genes Implicated by De Novo Mutation and CNV Morbidity
Medulloblastomas Overexpress the P53-Inactivating Oncogene WIP1/PPM1D
PPM1D Gene Amplification and Overexpression in Breast Cancer: a Qrt-PCR and Chromogenic in Situ Hybridization Study
Medulloblastomas Overexpress the P53-Inactivating Oncogene WIP1/PPM1D
Truncated PPM1D Prevents Apoptosis in the Murine Thymus and Promotes Ionizing Radiation-Induced Lymphoma